Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial

Yuen Siang Ang, Gerard E. Bruder, John G. Keilp, Ashleigh Rutherford, Daniel M. Alschuler, Pia Pechtel, Christian A. Webb, Thomas Carmody, Maurizio Fava, Cristina Cusin, Patrick J. McGrath, Myrna Weissman, Ramin Parsey, Maria A. Oquendo, Melvin G. McInnis, Crystal Cooper Cortes, Patricia Deldin, Madhukar H. Trivedi, Diego A. Pizzagalli

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences